Quantcast
Last updated on April 18, 2014 at 1:21 EDT

New, Clinically Validated, Natural Solution for Occasional Anxiety Introduced to the United States

January 30, 2012

GREEN BAY, Wis., Jan. 30, 2012 /PRNewswire/ — For the first time, an exclusive lavender (Lavandula angustifolia) essential oil indicated for occasional anxiety is being introduced to the United States. This clinically validated oil – Lavela WS 1265(TM) is available through the practitioner exclusive brand – Integrative Therapeutics(TM).

Indicated for occasional anxiety, Lavela WS 1265 (referred to as Silexan® in published research), has been shown to promote relaxation and calm nervousness with safety and efficacy, as demonstrated in controlled trials published in peer-reviewed medical journals.(*1,2) Lavela WS 1265 offers relief without the side effects commonly seen in other options. Taken just once a day, this gentle, yet powerful, essential oil is non-habit-forming and well-tolerated. Clinical trials and a comparative analysis suggest that the effects of Lavela WS 1265 compare favorably to other options.(*1-3)

Integrative Therapeutics adds this product to a line up of other clinically-validated natural products including ViraClear EPs 7630.

Integrative Therapeutics, LLC manufactures and distributes proprietary, natural supplements exclusively to medical professionals. Its manufacturing facility meets stringent quality standards and is an FDA-registered drug establishment. In addition to providing superior quality products, Integrative Therapeutics offers a variety of practitioner resources including educational events. Find out more at http://www.integrativeinc.com

1. Kasper S, Gastpar M, Muller WE, et al. Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of ‘subsyndromal’ anxiety disorder: a randomized, double-blind, placebo controlled trial. Int Clin Psychopharmacol 2010 Sep;25(5):277-87.

2. Woelk H, Schalfke S. A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder. Phytomedicine 2010;17:94-99.

3. Hidalgo RB, Tupler LA, Davidson JR. An effect-size analysis of pharmacologic treatments for generalized anxiety disorder. J Psychopharmacol 2007;21:864-72.

SOURCE Integrative Therapeutics, LLC


Source: PR Newswire